SMSH + TIP-C for Cancer Survivors' Well-being
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a guidebook for managing symptoms and phone counseling for emotional support in cancer survivors and their caregivers, especially those in rural areas. The guidebook offers practical advice, while the counseling helps reduce stress and anxiety.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your healthcare provider.
Is the SMSH + TIP-C treatment safe for cancer survivors?
How is the SMSH + TIP-C treatment different from other treatments for cancer survivors?
The SMSH + TIP-C treatment is unique because it combines a handbook for managing symptoms and survivorship with telephone counseling to support cancer survivors' well-being. This approach is novel as it simultaneously addresses both psychosocial and health behavior outcomes through personalized support, which is not commonly found in other treatments.23567
What data supports the effectiveness of the treatment SMSH + TIP-C for Cancer Survivors' Well-being?
Research shows that telephone counseling and self-management interventions can improve the quality of life and coping skills for cancer survivors. For example, a study on telephone counseling for breast cancer survivors found it helped with mood, social support, and self-efficacy. Additionally, self-management interventions have been beneficial in helping survivors manage their health and well-being post-treatment.12589
Who Is on the Research Team?
Chris Segrin, Ph.D.
Principal Investigator
University of Arizona
Are You a Good Fit for This Trial?
This trial is for adult cancer survivors who've finished treatment within the last 2 years and their caregivers. Participants must have telephone access, not be in therapy, be able to do daily tasks, and understand English or Spanish. Caregivers can be of any relation.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive weekly phone calls for symptom management and assessment using the General Symptom Management Scale (GSDS) over 16 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment, including two exit interviews
What Are the Treatments Tested in This Trial?
Interventions
- Adaptive Symptom Management and Survivorship Handbook (SMSH) and Telephone Interpersonal Counseling (TIP-C)
- NCI Brochure
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Arizona
Lead Sponsor
American Cancer Society, Inc.
Collaborator